IL44230A - 3-substituted-1-(4-(2-(4-methyl-5-thiazolecarboxamido)-ethyl) benzenesulfonyl)urea derivatives and pharmaceutical compositions containing them - Google Patents

3-substituted-1-(4-(2-(4-methyl-5-thiazolecarboxamido)-ethyl) benzenesulfonyl)urea derivatives and pharmaceutical compositions containing them

Info

Publication number
IL44230A
IL44230A IL44230A IL4423074A IL44230A IL 44230 A IL44230 A IL 44230A IL 44230 A IL44230 A IL 44230A IL 4423074 A IL4423074 A IL 4423074A IL 44230 A IL44230 A IL 44230A
Authority
IL
Israel
Prior art keywords
methyl
ethyl
thiazolecarboxamido
benzenesulfonyl
substituted
Prior art date
Application number
IL44230A
Other languages
English (en)
Other versions
IL44230A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL44230A0 publication Critical patent/IL44230A0/xx
Publication of IL44230A publication Critical patent/IL44230A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
IL44230A 1973-03-07 1974-02-18 3-substituted-1-(4-(2-(4-methyl-5-thiazolecarboxamido)-ethyl) benzenesulfonyl)urea derivatives and pharmaceutical compositions containing them IL44230A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00338965A US3856806A (en) 1973-03-07 1973-03-07 Thiazolecarboxamide sulfonylurea hypoglycemic agents

Publications (2)

Publication Number Publication Date
IL44230A0 IL44230A0 (en) 1974-05-16
IL44230A true IL44230A (en) 1976-12-31

Family

ID=23326893

Family Applications (1)

Application Number Title Priority Date Filing Date
IL44230A IL44230A (en) 1973-03-07 1974-02-18 3-substituted-1-(4-(2-(4-methyl-5-thiazolecarboxamido)-ethyl) benzenesulfonyl)urea derivatives and pharmaceutical compositions containing them

Country Status (29)

Country Link
US (1) US3856806A (fr)
JP (1) JPS5418258B2 (fr)
AR (1) AR201135A1 (fr)
AT (1) AT342614B (fr)
AU (1) AU458655B2 (fr)
BE (1) BE811866A (fr)
BG (1) BG25376A3 (fr)
CA (1) CA1015362A (fr)
CH (1) CH581639A5 (fr)
CS (1) CS176268B2 (fr)
DD (1) DD110500A5 (fr)
DE (1) DE2410003A1 (fr)
DK (1) DK139579B (fr)
EG (1) EG11270A (fr)
ES (1) ES423865A1 (fr)
FI (1) FI55034C (fr)
FR (1) FR2220259B1 (fr)
GB (1) GB1409518A (fr)
HU (1) HU167511B (fr)
IE (1) IE38955B1 (fr)
IL (1) IL44230A (fr)
LU (1) LU69565A1 (fr)
NL (1) NL7402804A (fr)
NO (1) NO140820C (fr)
PL (1) PL96884B1 (fr)
RO (1) RO69724A (fr)
SE (1) SE393984B (fr)
SU (1) SU617012A3 (fr)
ZA (1) ZA741439B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714920D0 (en) * 1987-06-25 1987-07-29 Shell Int Research Thiazole derivatives

Also Published As

Publication number Publication date
DK139579B (da) 1979-03-12
NO140820C (no) 1979-11-21
EG11270A (en) 1977-08-15
NO740532L (no) 1974-09-10
SE393984B (sv) 1977-05-31
IL44230A0 (en) 1974-05-16
ES423865A1 (es) 1976-03-16
AU6586474A (en) 1975-03-06
AT342614B (de) 1978-04-10
JPS5418258B2 (fr) 1979-07-06
NO140820B (no) 1979-08-13
GB1409518A (en) 1975-10-08
FI55034B (fi) 1979-01-31
BG25376A3 (en) 1978-09-15
CH581639A5 (fr) 1976-11-15
FR2220259B1 (fr) 1977-10-28
DK139579C (fr) 1979-08-27
PL96884B1 (pl) 1978-01-31
DE2410003A1 (de) 1974-09-26
AR201135A1 (es) 1975-02-14
FI55034C (fi) 1979-05-10
FR2220259A1 (fr) 1974-10-04
CS176268B2 (fr) 1977-06-30
RO69724A (fr) 1981-04-30
HU167511B (fr) 1975-10-28
IE38955B1 (en) 1978-07-05
LU69565A1 (fr) 1974-10-09
US3856806A (en) 1974-12-24
JPS5029557A (fr) 1975-03-25
IE38955L (en) 1974-09-07
AU458655B2 (en) 1975-03-06
SU617012A3 (ru) 1978-07-25
BE811866A (fr) 1974-09-05
ATA174074A (de) 1977-08-15
CA1015362A (en) 1977-08-09
NL7402804A (fr) 1974-09-10
ZA741439B (en) 1975-02-26
DD110500A5 (fr) 1974-12-20

Similar Documents

Publication Publication Date Title
NO177535C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidforbindelser
AU584153B2 (en) Naphthalene derivatives and processes of preparation thereof
HUT68721A (en) Benzofuran and benzizoxazole derivatives, pharmaceutical composition containing said compounds as active agent and process for preparing them
NO911525D0 (no) Nye 2,9-disubstituerte-4h-pyrido(1,2-a)pyrimidin-4-oner.
FI874865A0 (fi) Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi
SE8705150D0 (sv) Novel antiarrhythmic agents
HU9401161D0 (en) Oxazolidone derivatives, process for producing them and pharmaceutical compositions containing them
NO891176D0 (no) Fremstilling av antivirale tetrahydroimidazo(1,4)benzodiazepin-2-oner.
IL44230A (en) 3-substituted-1-(4-(2-(4-methyl-5-thiazolecarboxamido)-ethyl) benzenesulfonyl)urea derivatives and pharmaceutical compositions containing them
FI872930A0 (fi) Analogiamenetelmä ripulinvastaisten 4-(bentsoyyliamino)piperidiinibutaaniamidijohdannaisten valmistamiseksi
GB1450801A (en) Pyridinecarboxamide sulphonylurea hypoglycemic agents
HK1032237A1 (en) 2, 3-methano-amino acid compounds, a process for their preparation and pharmaceutical compositions containing them
GB1161062A (en) Active Sulphonamides
GB1481948A (en) 2-(disubstituted-amino)-4-phenyl-imidazolines and their use in pharmaceutical compositions
DE3781044D1 (de) Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung.
GB1496710A (en) Furotriazines
IL42343A (en) N-substituted-n'-((benzoxazole-7-carboxamidoalkyl)benzene-sulfonyl)ureas and process for their manufacture
TH17758A (th) สารเคมี
KR900004680A (ko) 사이클로알킬-치환된 글루타르아미드 고혈압 치료제